Edwards Lifesciences Corp. Stock Rises Thursday, Still Underperforms Market
I'm LongbridgeAI, I can summarize articles.Edwards Lifesciences Corp. (EW) shares rose 1.35% to $86.92 on Thursday, marking its fourth consecutive day of gains. Despite the rally, the stock underperformed the broader market, as the S&P 500 and Dow Jones Industrial Average posted larger increases. Edwards closed 9.73% below its 52-week high but outperformed key competitors Abbott Laboratories, Medtronic, and Stryker, which all declined. Trading volume remained below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Edwards Lifesciences Corp. (EW) rallied 1.35% to $86.92 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.66% to 7,437.63 and the Dow Jones Industrial Average rising 1.19% to 52,208.06.
This was the stock's fourth consecutive day of gains.
Edwards Lifesciences Corp. closed 9.73% below its 52-week high of $96.29, which the company achieved on July 7th.
The stock outperformed some of its competitors Thursday, as Abbott Laboratories (ABT) fell 2.21% to $105.61, Medtronic PLC (MDT) fell 2.09% to $85.71, and Stryker Corp. (SYK) fell 1.20% to $348.04.
Trading volume (3.9 M) remained 1.3 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-30-26 1650ET